The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase 2 study of NEO-102 (ensituximab), a novel chimeric monoclonal antibody, in adult patients (pts) with unresectable, metastatic colorectal cancer (mCRC).
 
Richard D. Kim
Honoraria - Bristol-Myers Squibb
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Genentech; Lilly
Speakers' Bureau - Bristol-Myers Squibb; Sanofi
Research Funding - Bayer; Novartis
 
Nilofer Saba Azad
Honoraria - Merck
Consulting or Advisory Role - Dava Oncology
Research Funding - Agios (Inst); Astex Pharmaceuticals (Inst); Celgene (Inst); Genentech (Inst); Kinex (Inst); Precision Biologics (Inst)
Travel, Accommodations, Expenses - Merck
 
Michael Morse
Stock and Other Ownership Interests - PhytoChem
Honoraria - Astellas Pharma; Bayer; Boehringer Ingelheim; EMD Serono; Etubics; Genentech/Roche; Ipsen; Lexicon; Merrimack; Novartis; Onyx; Regeneron; Sanofi; Taiho Pharmaceutical
Speakers' Bureau - Celgene; Genentech/Roche; Novartis
Research Funding - Advanced Accelerator Applications (Inst); AlphaVax (Inst); Bristol-Myers Squibb (Inst); Eisai (Inst); Lexicon (Inst); MedImmune (Inst); Onyx (Inst); Precision Biologics (Inst)
 
Benjamin R. Tan
Consulting or Advisory Role - Roche/Genentech
Research Funding - Bayer; Eisai; Exelixis; Lilly; Merck Serono; Pfizer; Roche/Genentech; Xcovery
 
Elizabeth Poplin
Stock and Other Ownership Interests - Celgene (I); Exelixis; Gilead Sciences (I); Pacira Pharmaceuticals (I); TEVA; Teva (I)
Research Funding - Clovis Oncology (Inst); Neogenix Oncology (Inst)
Travel, Accommodations, Expenses - Clovis Oncology
 
Melony A. Beatson
Employment - Precision Biologics
 
Sharon Mavroukakis
Employment - Precision Biologics
Leadership - Precision Biologics
 
Karen Cui
Employment - Precision Biologics
 
Philip M. Arlen
Employment - Precision Biologics
Leadership - Precision Biologics
Stock and Other Ownership Interests - Precision Biologics
 
Muhammad Shaalan Beg
Consulting or Advisory Role - Bayer; Celgene; Ipsen
Research Funding - Celgene; miRNA Therapeutics; Precision Biologics
Travel, Accommodations, Expenses - miRNA Therapeutics; Precision Biologics